Inventor
RANGAN VANGIPURAM S
US4 patents
Patents
4 patentsUS12077584B2Sep 3, 2024
Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)
BRISTOL MYERS SQUIBB CO1 citations69
US11274150B2Mar 15, 2022
Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies
BRISTOL MYERS SQUIBB CO2 citations69
US11981734B2May 14, 2024
Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
BRISTOL MYERS SQUIBB CO0 citations59
US10279049B2May 7, 2019
Antibody-drug conjugates of tubulysin analogs with enhanced stability
BRISTOL MYERS SQUIBB CO0 citations34